{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T10:10:49Z","timestamp":1772187049406,"version":"3.50.1"},"reference-count":20,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Obstet and Gynaecol"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aim<\/jats:title><jats:p>Self\u2010sampling human papillomavirus (HPV) testing has been introduced for cervical cancer screening worldwide. In Japan, there are two types (brush and sponge) of HPV self\u2010sampling devices. However, the recommended type for cervical cancer screening remains unclear. This study aimed to evaluate the feasibility of the HPV self\u2010sampling device\u2013sponge type (HSD\u2010ST). Additionally, we aimed to examine the positive rate (sensitivity) for cervical intraepithelial neoplasia (CIN) 2 or worse using the HSD\u2010ST. Finally, we aimed to perform a questionnaire survey regarding the usability of the HSD\u2010ST.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We included 165 women who underwent HPV testing at one of three gynecologic clinics. First, the women used the HSD\u2010ST and completed a questionnaire regarding its usability. Subsequently, they underwent physician\u2010sampling HPV testing and cytology. We examined the agreement rate of HPV positivity between self\u2010 and physician\u2010sampling HPV testing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The HPV\u2010positive rates of self\u2010 and physician\u2010collected samples were 59.4% and 62.4%, respectively, with an overall concordance rate of 88.5% and a calculated kappa coefficient of 0.76, indicating high concordance. Moreover, the positive (sensitivity) rates for CIN2 or worse were 81.4% and 89.8% in the self\u2010 and physician\u2010collected samples, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our findings demonstrated the feasibility and usability of the HSD\u2010ST.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jog.15496","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T02:06:05Z","timestamp":1671156365000},"page":"701-708","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of the feasibility of human papillomavirus sponge\u2010type self\u2010sampling device at Japanese colposcopy clinics"],"prefix":"10.1111","volume":"49","author":[{"given":"Nobuyoshi","family":"Ozawa","sequence":"first","affiliation":[{"name":"Ozawa Women's General Clinic  Sendai Miyagi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9306-166X","authenticated-orcid":false,"given":"Tetsuji","family":"Kurokawa","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medical Sciences University of Fukui  Fukui Fukui Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Hareyama","sequence":"additional","affiliation":[{"name":"Sapporo Women's JR\u2010Tower Clinic  Sapporo Hokkaido Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Tanaka Women's Clinic  Saga Saga Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiro","family":"Satoh","sequence":"additional","affiliation":[{"name":"Division of Public Health, Hygiene and Epidemiology, Faculty of Medicine Tohoku Medical and Pharmaceutical University  Sendai Miyagi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1894-3328","authenticated-orcid":false,"given":"Hirohito","family":"Metoki","sequence":"additional","affiliation":[{"name":"Division of Public Health, Hygiene and Epidemiology, Faculty of Medicine Tohoku Medical and Pharmaceutical University  Sendai Miyagi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuaki","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Japan Association of Obstetricians and Gynecologists  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"key":"e_1_2_9_2_1","unstructured":"WHO Classification of Tumours Editorial Board.Female genital tumours WHO classification of tumours.5th ed.France:Interntional agency for research on cancer;2020. p.347\u20138."},{"key":"e_1_2_9_3_1","unstructured":"The Global Cancer Observatory [Internet]. International Agency for Research on Cancer in World Health Organization. 2022 [cited 2022 Aug 22]. Available from:https:\/\/gco.iarc.fr\/overtime\/en"},{"key":"e_1_2_9_4_1","unstructured":"Cancer Information Service National Cancer Center Japan. Prefectural Cancer Screening Rate (2007\u20132019) Cancer Registry and Statistics. Available from:https:\/\/ganjoho.jp\/reg_stat\/statistics\/stat\/screening\/dl_screening.html#a18. Accessed 07 Dec 2021."},{"key":"e_1_2_9_5_1","doi-asserted-by":"crossref","unstructured":"OECD.Health at a Glance 2015. Available from:https:\/\/doi.org\/10.1787\/health_glance-2015-en. Accessed 07 Dec 2021.","DOI":"10.1787\/health_glance-2015-en"},{"key":"e_1_2_9_6_1","unstructured":"National Cancer Center Japan.The Japanese guideline for Cervical Cancer Screening 2009. Available from:http:\/\/canscreen.ncc.go.jp\/guideline\/shikyukeigan.html. Accessed 20 Dec 2021."},{"key":"e_1_2_9_7_1","unstructured":"National Cancer Center Japan.The Japanese guideline for Cervical Cancer Screening 2019. Available from:http:\/\/canscreen.ncc.go.jp\/guideline\/shikyukeigan.html. Accessed 20 Dec 2021."},{"key":"e_1_2_9_8_1","unstructured":"World Health Organization.Guidance on regulations for the transport of infectious substances 2013\u20132014: applicable as from 1 January 2013. Available from:https:\/\/apps.who.int\/iris\/handle\/10665\/78075. Accessed 07 Dec 2021."},{"key":"e_1_2_9_9_1","unstructured":"Roche Diagnostics KK.Package inset of Cobas 4800 HPV Kit. 7th ed. revised Oct 2018. Available from:https:\/\/www.info.pmda.go.jp\/downfiles\/ivd\/PDF\/700025_22400AMX01429000_A_01_09.pdf. Accessed 21 Apr 2022."},{"key":"e_1_2_9_10_1","unstructured":"National Institute for Public Health and the Environment Ministry of Health Welfare and Sport. Available from:https:\/\/www.rivm.nl\/en\/cervical-cancer-screening-programme. Accessed 21 Apr 2022."},{"key":"e_1_2_9_11_1","unstructured":"Australian Government Department of Health. Available from:https:\/\/www.health.gov.au\/resources\/publications\/national-cervical-screening-program-self-collection-and-the-cervical-screening-test. Accessed 21 Apr 2022."},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S288376"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2006.03.021"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2011.05.006"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2012.02.022"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3254-y"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70570-99"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1159\/000507342"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-020-01727-5"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/jog.13258"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1159\/000320924"}],"container-title":["Journal of Obstetrics and Gynaecology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jog.15496","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jog.15496","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jog.15496","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T18:18:12Z","timestamp":1692382692000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/jog.15496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10.1111\/jog.15496"],"URL":"https:\/\/doi.org\/10.1111\/jog.15496","archive":["Portico"],"relation":{},"ISSN":["1341-8076","1447-0756"],"issn-type":[{"value":"1341-8076","type":"print"},{"value":"1447-0756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"assertion":[{"value":"2022-07-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}